A seminar at the College of Pharmacy at Al-Qadisiyah University on the new generation of CGRP antagonists that work on the calcitonin gene related peptide (CGRP) receptor

Under the patronage of the President of Al-Qadisiyah University, Professor Dr. Kazem Jabr Al-Jubouri, and under the supervision of the Dean of the College of Pharmacy, Assistant Professor Dr. Asaad Hassan Al-Zaidi, the College of Pharmacy held a seminar entitled A new generation of CGRP antagonists that work on the calcitonin gene related peptide (CGRP) receptor

The most important of which is Gepants and their role in the prevention and treatment of acute migraine

This group is considered the first preventive treatment for migraine headaches to be approved by the FDA. These drugs (Rimegepant, ubrogepant, atogepant and zavegepant) were discussed and their effectiveness and strength were compared with traditional migraine medications such as triptans. The side effects and precautions for this group were also discussed, as these drugs Gepants are considered the first choice for migraine headaches in patients suffering from heart disease and cerebrovascular diseases or those who have Medical histo

ry